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Background: Spinal cord injury (SCI) and its accompanying changes of brain structure
and function have been widely studied and reviewed. Debilitating chronic neuropathic
pain (NP) is reported in 53% of SCI patients, and brain changes have been shown to
be involved with the presence of this secondary complication. However, there is yet a
synthesis of current studies that investigated brain structure, resting connectivity, and
metabolite changes that accompanies this condition.
Methods: In this review, a systematic search was performed using Medical Subject
Headings heading search terms in PubMed and SCOPUS to gather the appropriate
published studies. Neuroimaging studies that investigated supraspinal structural, resting-
state connectivity, and metabolite changes in SCI subjects with NP were included. To this
end, voxel-based morphometry, diffusion tensor imaging, resting-state functional MRI,
magnetic resonance spectroscopy, and PET studies were summarized and reviewed.
Further inclusion and exclusion criteria allowed delineation of appropriate studies that
included SCI subgroups with and without NP.
Results: A total of 12 studies were eligible for qualitative synthesis. Overall, current
studies that investigated NP-associated changes within the SCI cohort show primarily
metabolite concentration alterations in sensory-pain processing regions, alongside
bidirectional changes of brain structure. Moreover, in comparison to healthy controls,
there remains limited evidence of structural and connectivity changes but a range of
alterations in metabolite concentrations in SCI subjects with NP.
Conclusions: There is some evidence suggesting that the magnitude and presence
of NP following SCI results in both adaptive and maladaptive structural plasticity
of sensorimotor regions, alongside altered metabolism of brain areas involved with
descending pain modulation, pain perception (i.e., anterior cingulate cortex) and sensory
integration (i.e., thalamus). However, based on the fact that only a few studies
investigated structural and glucose metabolic changes in chronic SCI subjects with
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
9
4
5
8
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
4
.
1
.
2
0
2
1
Huynh et al. Neuroimaging Neuropathic Pain After SCI
NP, the underlying mechanisms that accompany this condition remains to be further
elucidated. Future cross-sectional or longitudinal studies that aim to disentangle NP
related to SCI may benefit from stricter constraints in subject cohorts, controlled
subgroups, improved pain phenotyping, and implementation of multimodal approaches
to discover sensitive biomarkers that profile pain and optimize treatment in SCI subjects
with NP.
Keywords: neuroimaging, spinal cord injury, neuropathic pain, brain plasticity, systematic review
INTRODUCTION
Rationale
Spinal cord injury (SCI) has severe consequences for the
individual, commonly causing distinct motor and sensory deficits
below the level of lesion, attributed to the damage of the
corresponding efferent and afferent neural pathways. Disruption
of the somatosensory system after SCI can lead to debilitating
chronic neuropathic pain (NP) prevalent in 53% of subjects (1)
with a third reporting it to be severe (2). NP is defined by the
International Association for the Study of Pain (IASP) as “pain
arising as a direct consequence of a lesion or disease affecting
the (central) somatosensory system” (3, 4). The pathophysiology
of NP involves a complex interaction of neuronal changes,
inflammation, glial–neuron interactions, supraspinal and spinal
sensitization, and alterations in endogenous pain modulation
[see reviews: (5–9)]. Consequences of these mechanistic changes
are chronic alterations of nociceptive pathways and pain
processing regions within the central nervous system, i.e., spinal
cord, brainstem, and the brain. Indeed, current neuroimaging
studies investigating chronic pain conditions, i.e., fibromyalgia,
complex regional pain syndrome, and chronic low back pain
have observed changes in brain structure (10, 11), resting-state
connectivity (12–14), and metabolic function (15). Furthermore,
gray matter volume in chronic low back pain (16) and
connectivity changes in fibromyalgia subjects (17), respectively,
were shown to be reversed concurrently following pain treatment
(16, 17). Together, these studies suggest that changes of structural
and functional plasticity within the brain accompany those who
experience chronic pain [see reviews: (18, 19)]. However, in
cross-sectional studies alone, determining whether the observed
brain differences in chronic pain conditions are pre-existing the
pain condition, a marker of chronic pain predisposition, or a
direct cause of the pain condition itself remains debatable.
Nevertheless, within the last few years, advanced magnetic
resonance imaging (MRI) has provided a valuable tool to
investigate the structural and/or functional correlates of NP in
the brain (5, 18, 20–22). In this context, four MRI methods have
been mainly used:
(1) Structural imaging including voxel-based morphometry
(VBM) and voxel-based cortical thickness (VBCT). VBM
is an imaging-based analysis method for quantifying
changes in gray and white matter volume (GMV
and WMV, respectively) (23). VBCT is an applied
surface-based metric to study atrophy (24). Both
methods can provide complementary information of
alterations in density and thickness of brain areas in
diseases (25).
(2) Diffusion tensor imaging (DTI) measures the diffusion of
water molecules in each image voxel and allows indirect
quantification of peripheral and central WM integrity and
myelination. In the nervous tissue, physical properties such
as neuronal density, axon diameter, fiber bundles, and
degree of myelination all affect diffusion metrics (26, 27).
Fractional anisotropy (FA) and mean diffusivity (MD) are
most commonly used DTI metrics (28–30). FA measures
the anisotropy of tissue architecture by the preferential
direction of water movement, i.e., water molecules diffuse
along the direction of tightly packed axons, whereas MD
measures the degree of water diffusion. DTI can also visualize
and trace WM tracts indirectly with tractography, which
can provide anatomical information on specific fibers of
interest (31, 32). Yet, careful interpretation is required as
several possible substrates can impact on DTI measures
and findings may be heterogenous in different neurological
disorders (33).
(3) Functional MRI (fMRI) informs about brain function,
measured by alterations in the blood oxygen level-dependent
signal (34) or by arterial spin labeling (35) that provides
a measure of cerebral blood flow. Under task conditions,
the hemodynamic response can primarily reflect the
local processing of a brain region (36). fMRI can also
measure functional connectivity under resting (rsfMRI)
or task conditions. This method utilizes the blood oxygen
level-dependent signal to define brain areas that have
low-frequency synchronous coactivation or resting-state
functional connectivity (rsFC).
(4) Magnetic resonance spectroscopy (MRS) (37) provides in
vivo biochemical information including N-acetyl aspartate
(NAA), myo-inositol (Ins), creatine (Cr), combined
measures of glutamate and glutamine (Glx), glutamate
(Glu), choline (Cho), and gamma(γ )-aminobutyric acid
(GABA). This method allows the determination of metabolite
concentrations of certain brain regions and is valuable
to investigate underlying biochemical changes that may
complement structural and functional observations in
clinical populations (38–40).
Next to MRI-based methods, positron emission tomography
(PET) can be used to investigate neurochemical changes, i.e.,
molecular processes, receptor activity, or density alongside
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FIGURE 1 | Flow diagrnm of the method followed through the systematic review according to PRISMA standards.
blood flow and glucose metabolism in a variety of clinical
applications (41–43).
To date, recent reviews and a meta-analysis have summarized
the cortical alterations, alongside metabolite and functional
changes after SCI [for reviews and meta-analysis, see (44–47)]. In
addition, two reviews summarized the impact of deafferentation
and chronic pain upon brain reorganization reported with task-
based fMRI in animal and human studies (20, 48). However,
possibly due to the heterogeneous nature of SCI, i.e., variable
injury level and completeness (American Spinal Cord Injury
Association Impairment Scale) (49), injury duration, extent of
deafferentation (50, 51), and varied clinical characteristics of NP
(52), there is limited understanding of the associated changes of
brain structure, rsFC, and metabolism in SCI subjects with and
without NP.
Objectives
The overall aim of this systematic review is to determine how
current neuroimaging studies have provided understanding of
neuroplastic changes that possibly contributes to NP following
SCI. A variety of neuroimaging studies with different modalities
and parameters have appeared to investigate the changes of brain
structure and function that accompany chronic NP following
SCI, but a synthesis of the literature is lacking. This review
therefore expects to compile and examine the remote brain
changes as reported in the current literature in two particular SCI
states: (1) SCI without NP and (2) SCI with NP.
Research Questions
Specific research questions include the following:
(1) What are the brain correlates, i.e., structure, functional
connectivity, and metabolism that accompany NP after SCI?
(2) What have current neuroimaging results revealed regarding
the underlying pathophysiological mechanisms of NP
following SCI?
(3) What do future neuroimaging studies need to consider and
account for when investigating NP in SCI subjects?
METHODS
Study Design and Search Strategy
A search of the online databases PubMeD and SCOPUS was
conducted on the 1st July 2019 up to 1st August 2019. No
publication year criterion was set. The search was performed
using a combination of Medical Subject Headings (MeSH)
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keywords: “Tetraplegia,” “Quadriplegia,” “Paraplegia,” “Spinal
Cord Injury,” “Neuropathic Pain,” “Voxel Based Morphometry,”
“Voxel Based Cortical Thickness,” “Diffusion Tensor Imaging,”
“Diffusion Magnetic Resonance Imaging,” “DTI,” “Resting-
state fMRI,” “rs fMRI,” “Resting-State Functional Connectivity,”
“Functional Neuroimaging,” “Functional Magnetic Resonance
Imaging,” “fMRI,” “Magnetic Resonance Spectroscopy,” and
“Positron-Emission Tomography” to identify neuroimaging
studies investigating SCI subjects with and without NP.
Specifically, MeSH term combinations involved using logic term
“OR” between the SCI terms, i.e., Tetraplegia, Quadriplegia
etc. while the term “AND” was added to include the
neuroimaging method. To optimize the search for identifying
articles that investigated the NP condition, an additional “AND”
with “Neuropathic Pain” was placed after the neuroimaging
method (see Supplementary Table 1). To miss relevant studies,
bibliographies of identified studies were also hand searched.
One author (VH) initiated the article search utilizing MeSH
term combinations and filtered article abstracts for relevancy
after removal of duplicates. This yielded a preselection of 90
articles that were further inspected with the inclusion and
exclusion criteria for relevancy. Preselected articles (n= 90) were
additionally checked for inclusion and exclusion criteria by two
additional authors (MH and LM) (Figure 1).
Data Sources, Studies Sections, and Data
Extraction
All original studies that investigated supraspinal changes in
SCI subgroups with and without NP employing neuroimaging
methods were included. Studies that included SCI subjects but
lacked pain assessments were excluded. Studies that included
pain assessments but did not differentiate SCI subjects into
pain subgroups were not included in the qualitative synthesis
due to potential confounds in their results. Furthermore, non-
English studies, preclinical studies, electrophysiological studies,
case studies, intervention studies, review articles, and task-based
functional neuroimaging only studies were excluded.
The outcomes extracted and summarized from each study
included the following: (1) the modality of the neuroimaging
study and subjects’ pain assessment implemented in the article;
(2) subjects involved, i.e., number, age, chronicity of injury,
level of injury, sex, completeness of injury (i.e., Association
Impairment Scale A—sensorimotor complete) and presence of
NP as assessed by the study’s pain characterization (Table 2); (3)
whether the study implemented a whole brain and/or a region
of interest approach for data analysis; and (4) the main findings
of brain alterations from comparisons between healthy controls
and/or SCI subgroup (Tables 3–5).
RESULTS
Systematic Search Results
Initial search in the two databases and bibliographies yielded
2,921 articles after the removal of duplicate entries. Screening
of abstracts derived 90 articles that were manually screened
for relevance. Upon further inspection with the inclusion and
exclusion criteria, 35 were excluded due to being task-based
TABLE 1 | Overview of articles investigating brain alterations in SCI subjects
without or with NP included in qualitative synthesis.
References Modality HC (n) SCI (n) Pain
characterization
Chen et al. (53) sMRI* 13 13 VAS at MRI
acquisition
Chen et al. (54) sMRI,
rsfMRI
11 11 VAS at MRI
acquisition
Jutzeler et al.
(55)
sMRI 31 28 EMSCI pain
questionnaire, NRS
(0–10)
Mole et al. (56) sMRI 18 30 Below-level NP >1
year, NRS (4–10)
Yoon et al. (57) sMRI,
DTI, PET
10 10 ISCI basic pain
dataset, NRS (0–10)
Gustin et al. (58) DTI 45 23 IASP assessment,
NRS (0–10)
Min et al. (59)§ rsfMRI 18 18 VAS (0–100) at MRI
acquisition
Widerström-
Noga et al.
(60)
MRS 24 54 MPI-SCI, NRS (0–10),
pain diary
Gustin et al. (61) MRS* 21 22 IASP SCI pain
taxonomy, VAS
(0–10)
Widerström-
Noga et al.
(62)
MRS 24 68 MPI-SCI, NRS (4–10)
Stanwell et al.
(63)
MRS 10 10 Pain interview and
assessment
Pattany et al.
(64)
MRS 10 16 Pain interview,
drawings, NRS (0–10)
Summary of articles included in qualitative synthesis. Details include neuroimaging
modality, number of SCI subjects with or without NP, number of healthy controls, and
NP characterization used to differentiate or characterize SCI subjects. Ranges from 0 to
10 or 0 to 100 are commonly used to depict “no pain” to “worst pain imaginable” for NRS
and VAS.
DTI, diffusion tensor imaging; EMSCI, European Multicenter Study about Spinal Cord
Injury; HC, healthy controls; IASP, International Association for the Study of Pain; ISCI,
International Spinal Cord Injury; ISCIP, International Spinal Cord Injury Pain Classification;
MPI, multidimensional pain inventory; MRI, magnetic resonance imaging; MRS, magnetic
resonance spectroscopy; NP, neuropathic pain; NRS, numerical rating scale; PET,
positron emission tomography; rsfMRI, resting-state functional MRI; SCI, spinal cord
injury; sMRI, structural MRI; VAS, Visual Analog Scale.
*Study also included task-based fMRI results omitted in qualitative synthesis.
§Study did not identify whether pain was nociceptive or neuropathic.
only fMRI studies; 29 articles included SCI subjects but were
excluded due to lacking pain characterization or including
mixed cohorts (SCI with and without NP) for the analysis (see
Supplementary Table 2); 4 were intervention studies and 6 single
case studies were excluded; 1 was excluded due to being a book
chapter; and 3 were excluded due to other reasons (Figure 1,
Supplementary Table 2).
As a result, 12 articles were included in the synthesis (Table 1).
Four articles included sMRI (one study also included task-based
fMRI results that were omitted from the qualitative synthesis);
one study also included rsfMRI. One article included sMRI, DTI,
and PET. One study included DTI only. One study included
rsfMRI only. Five articles included MRS (one study included
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task-based fMRI results that were omitted from the qualitative
synthesis). Article findings are summarized and presented based
on the comparison between SCI subgroups to healthy controls
(Tables 4, 5) and between the two SCI subgroups (with/without
NP) (Table 3). Demographics of SCI subgroups are summarized
in Table 2.
Pain Assessments Implemented in
Included Articles
Within these studies, a range of pain assessments were used to
characterize the presence of pain in SCI subjects (Table 1). The
presence of NP in SCI subjects were characterized in nine studies
with interviews, pain drawings, and questionnaires (55–58, 60–
64) (Table 1). Three studies utilized a visual analog scale (VAS)
on the day of MRI acquisition to assess pain; NP assessment
was not mentioned (53, 54, 59). Seven studies characterized pain
intensity with a numerical rating scale (NRS) (55–58, 60–64); two
of these studies used NRS on the day of MRS acquisition (60, 64).
One study assessed pain intensity but did not report the scale of
which they used (63). Three studies characterized pain intensity
using a pain diary for a week (with VAS or NRS) before the day
of MRI/MRS acquisition (56, 58, 61). Two studies included SCI
subjects with NP who had a minimum pain rating of 4 (out of 10)
(56, 62).
Neuroimaging Studies Investigating NP
Within SCI
Based on the eligible articles, eight studies investigated the impact
of NP within SCI subjects (55, 56, 58, 60–64) (Table 2). Two
studies did not differentiate their SCI subjects as their whole
cohort had some degree of NP (57, 59) (Tables 1, 2).
Volumetric differences between chronic SCI subjects with and
without NP were reported in two studies (55, 56). In SCI subjects
with NP, one study observed increased GMV of the left anterior
cingulate cortex (ACC) and right M1 with decreased GMV of
the right S1 and bilateral thalamus (55). This study also showed
a positive correlation with pain intensity and GMV of M1 (55).
Another study showed decreased GMV of S1 and WMV of S2 in
SCI subjects with NP (56) alongside a negative correlation with
pain intensity and GMV of S1 (56).
Only one DTI study investigated microstructural differences
between chronic SCI subjects with and without NP (58). This
study observed decreased MD of the ventral pons to midbrain
region, alongside increased MD of prefrontal, premotor and
parietal cortices, anterior insula, thalamus, and amygdala in
SCI subjects with NP (58). In addition, MD values of the
anterior insular, prefrontal, premotor, and parietal cortices were
positively correlated with pain intensity, whereas MD values of
the amygdala and thalamus were negatively correlated with pain
intensity (58).
Four studies investigatedmetabolite concentration differences
between SCI subjects with and without NP (60–64). Two studies
observed decreased NAA/Cr and GABA/Cr ratios (61) and
decreased absolute Glx and Glx/Ins ratios (62) in the thalamus
of SCI subjects with NP. One study reported decreased Glx and
Glx/Ins ratios in the ACC of SCI subjects with NP compared to
those without NP (62). This study also investigated differences
between SCI subjects with differing amounts of NP intensity,
observing increased Ins, Cr, and Cho with decreased NAA/Ins
and Glx/Ins ratios in the ACC of SCI subjects with greater
NP intensity compared to those with a lower NP intensity
(62). Another study observed decreased NAA/Ins and Glx/Ins
within the thalamus of SCI subjects with greater NP intensity
compared to those with a lower NP intensity (60). One study
using wavelet-based statistics of MRS data identified mean
spectral differences within the prefrontal cortex (PFC) and ACC
(but not the thalamus) between SCI subjects with and without
NP (63). These differences may be related to a variety of
metabolite concentrations, i.e., NAA, GABA, Glu, Ins, and Asp
(63) (Table 3).
Neuroimaging Studies Investigating SCI
Subjects With NP Compared to Healthy
Controls
Eight articles compared SCI subjects with NP to healthy controls
(Table 4), showing a variable impact of SCI accompanied
by NP upon brain structure, bidirectional microstructural,
and connectivity changes and alterations in metabolite
concentrations compared to healthy cohorts.
Compared to healthy controls, volumetric changes in SCI
subjects with NP were reported in two studies (56, 57); one study
did not report this comparison (55). One study with 18 chronic
SCI subjects with NP observed no GMV changes but decreased
WMV in the bilateral pyramids, medial cuneus, secondary
somatosensory cortex (S2), and posterior corona radiata (56).
Another study using multimodal imaging in 10 SCI subjects
with NP observed decreased GMV in the medial frontal
gyrus, ACC, and anterior insula (57). This study also observed
decreased glucose metabolism in the frontal areas (57) and
widespread decreases in MD in white matter fibers (i.e.,
corticospinal tract, thalamocortical tract, and corpus callosum) as
well as in frontal regions and sensorimotor areas (57). No changes
in FA were observed (57) (Table 4).
Microstructural changes were reported in another study with
12 chronic SCI subjects with NP compared to healthy controls
(58). This study observed increased MD in the prefrontal,
parietal, and premotor cortices; decreased MD in the thalamus,
amygdala, and ventral pons; and no changes in FA (58) (Table 4).
Bidirectional connectivity changes were reported in 18 SCI
subjects with a varying amount of pain as identified on the
VAS (59). Decreases in rsFC between interhemispheric primary
motor cortex (M1), premotor cortex, S1, and S2 were observed
alongside increased rsFC of M1 to supplementary motor area
and the basal ganglia and S2 (Table 4) (59). Although unclear
whether the pain was neuropathic or nociceptive in this study,
no correlations between rsFC changes and pain severity were
reported (59).
Metabolite changes in the thalamus and ACC between
chronic SCI subjects with NP and healthy controls were
investigated in four studies (58, 60, 62, 64) (Table 4). Two
studies that investigated the thalamus observed decreases
in NAA/Ins and NAA/Cr ratios (60, 61), decreased
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TABLE 2 | Demographics of SCI subgroups included in the study.
References SCI
subjects
n Age
(years)
Sex
(m/f)
LOI AIS
(A–E)
TSI
(d, wks, mths, yrs)
Averaged
pain intensity
Chen et al. (53) SCI-NP 0 – – – – – –
SCI-no NP 13 51.3 ± 6.4 10/3 C3–C8 2B, 2C, 9D 11.7 ± 15.3 d 0
Chen et al. (54) SCI-NP 0 – – – – – –
SCI-no NP 11 50 ± 4.9 9/2 C3–C8 1B, 2C, 8D 10.0 ± 7.9 d 0
Jutzeler et al. (55) SCI-NP 13 46.9 ± 11.4 11/2 C2–L3 5A, 2B, 6D 12.8 + 8.4 yrs 4.0 ± 2.1
SCI-no NP 15 45.9 ± 12.8 15/0 C4–T12 6A, 3B, 2C, 4D 12.2 ± 7.7 yrs 0
Mole et al. (56) SCI-NP 18 51.3 ± 7.9 n/a C5–T5 n/a 11.1 ± 8.5 yrs 6.0 ± 1.6
SCI-no NP 12 54.3 + 16.9 n/a C5-T5 n/a
†A-D
17.7 ± 11.4 yrs 0
Yoon et al. (57) SCI-NP 10 39.8 ± 6.1 7/3 C4–T11 7A, 3B 18.4 ± 6.1 mths 7.6 ± 0.5
SCI-no NP 0 – – – – – –
Gustin et al. (58) SCI-NP 12 48.0 ± 4.0* n/a C8–T10 12A 16.0 ± 5 yrs* 4.3 ± 0.4
SCI-no NP 11 38.0 ± 3.0* n/a
†19/4
T3–T10 11A 13 ± 2 yrs* 0
Min et al. (59)§ SCI-NP§ 18 57.7 ± 11.9 12/6 C2–C7 5C, 13D 49.8 ± 33.7 wks 46.6 ± 23.3
SCI-no NP 0 – – – – – –
Widerström-Noga et al. (60) SCI-NP
SCI-HNP 19 43.0 ± 12.5 16/3 n/a 6A, 13B–D** 12.0 ± 9.7 yrs 6.4 ± 1.6
SCI-LNP 35 35.7 ± 12.4 28/7 n/a 24A, 11B–D** 13.1 ± 9.7 yrs 1.6 ± 1.5
SCI-no NP 0 – – – – – –
Gustin et al. (61) SCI-NP 12 57.0 ± 4.0* 8/4 T3–T12 12A n/a 3.6 ± 0.8
SCI-no NP 10 50.0 ± 4.0* 8/2 T3–T10 10A n/a 0
Widerström-Noga et al. (62) SCI-NP
SCI-HNP 19 40.4 ± 11.8 14/5 C–S5** 9A, 10B–D** 12.0 ± 9.9 yrs ∼4.1 ± 0.8
SCI-LNP 31 37.5 ± 13.4 26/5 C–S5** 17A, 14B–D** 10.6 ± 9.1 yrs ∼3.1 ± 1.0
SCI-no NP 18 36.8 ± 11.0 14/4 C-S5** 14A, 3B–D**,
1 n/a
16.2 ± 9.5 yrs –
Stanwell et al. (63) SCI-NP 5 n/a n/a n/a 5A 63.6 ± 49.6 mths n/a
SCI-no NP 5 n/a
†36.4 ± 10.4
n/a n/a
†T
5A 58.2 ± 59.7 mths n/a
Pattany et al. (64) SCI-NP 7 46.2 ± 16.2 7/0 C8–L3 n/a 7.6 ± 6.3 yrs 5<**
SCI-no NP 9 34.8 ± 10.0 9/0 C4–L3 n/a 11.3 ± 9.6 yrs 0
Summary of demographics for SCI subgroups as described in each study. Study order is based on neuroimaging modality as reported in Table 1, starting with structural, DTI, rsfMRI,
then MRS. Averaged pain intensity: ranges from 0 to 10 or 0 to 100 are commonly used to depict “no pain” to “worst pain imaginable” on a numerical rating scale and visual analog
scale, respectively.
AIS, ASIA Impairment Scale (A, sensorimotor complete; B, motor complete, sensory incomplete; C and D, sensory motor incomplete; E, normal); C, cervical level; d, days; f, female; L,
lumbar level; LOI, level of injury; m, male; mths, months; n/a, not available; NP, neuropathic pain; S, sacral level; SCI, spinal cord injury; SCI-HNP, SCI subjects with high NP; SCI-LNP,
SCI subjects with low NP; SCI-NP, SCI subjects with NP; SCI-no NP, SCI subjects without NP; T, thoracic level; TSI, time since injury; wks, weeks; yrs, years.
Traumatic SCI.
*Standard error of mean.
**Unspecified information.
∼Multidimensional pain inventory—SCI version subscale: pain severity.
§Study did not identify whether pain was nociceptive or neuropathic.
† Mean and standard deviation of whole SCI cohort.
Glx/Ins ratio (60), and GABA/Cr ratio (61). One study
investigating SCI subjects with a mild NP showed no
significant metabolite alterations in the thalamus compared
to healthy controls (60); another study also found no changes
in metabolite concentrations in the thalamus (64). One
study reports decreased Glx/Ins ratios within the ACC of
SCI subjects with more severe NP compared to healthy
controls (62).
Neuroimaging Studies Investigating SCI
Subjects Without NP Compared to Healthy
Controls
Based on the eligible articles, SCI subjects without NP show
variable alterations in brain structure and decreased connectivity
of frontal and visual areas and metabolite concentrations in the
thalamus compared to the healthy condition (53–56, 58, 61, 62,
64) (Table 5).
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TABLE 3 | Neuroimaging studies investigating NP within the SCI cohort.
References Modality Region of interest(s) Statistical correction Main findings
Jutzeler et al. (55) sMRI Whole brain;
M1, S1, S2, PMC, insula,
thalamus, ACC as regions of
interests
p < 0.05 FWE correction SCI-NP vs. SCI-no NP:
(Whole brain):↔ GMV
(Regions of interest):
↑ GMV in L ACC and R M1
Pain intensity correlated positively with
GMV in R M1
↓ GMV in R S1 and bilateral thalamus.
Mole et al. (56) sMRI Whole brain:
M1, S1, thalamus,
L posterior cingulate, R insula as
regions of interests
p < 0.001 uncorrected;
p < 0.05 FWE correction
SCI-NP vs. SCI-no NP:
↓ GMV in bilateral S1. Pain intensity
correlated negatively with GMV in S1
↓ WMV deep to S2
Min et al. (59)§ rsfMRI Bilateral M1,
SMA, S1, S2, BG, dlPM, vlPM
p < 0.05, k = 64
FDR correction
SCI-pain vs. SCI-no pain: n/a
Yoon et al. (57) sMRI
DTI
PET
Whole
brain
sMRI and PET:
p < 0.001 uncorrected,
p < 0.05 SVC with 10mm
spheres;
DTI: p < 0.05 TFCE
SCI-NP vs. SCI-no NP: n/a
Gustin et al. (58) DTI Whole
brain
p < 0.005 uncorrected,
k = 20
SCI-NP vs. SCI-no NP:
↓ MD of ventral pons to midbrain. ↑ MD of
R PPC, R dorsolateral PFC, L anterior
insula, mOFC, PMC, L amygdala, and R
ventroposterior thalamus.
MD values of dorsolateral PFC, PPC,
anterior insula and PMC were positively
correlated with pain intensity.
MD values of amygdala and
ventroposterior thalamus were negatively
correlated with pain intensity. ↔ FA.
Widerström-
Noga et al. (60)
MRS Thalamus Independent t tests
p < 0.05
SCI-NP high pain vs. low pain:
↓ NAA/Ins and Glx/Ins
Gustin et al. (61) MRS Thalamus Independent t tests
p < 0.05
SCI NP vs. SCI no NP:
NAA/Cr and GABA/Cr
Widerström-Noga
et al. (62)
MRS ACC Independent t tests
p < 0.05
SCI-NP high pain vs. low pain:
Ins, Cr and Cho ↓ NAA/Ins and Glx/Ins
SCI-NP high pain vs. SCI no NP:
↓ Glx ↓ Glx/Ins
Stanwell et al.
(63)
MRS Thalamus, PFC, ACC Wavelet-based significant
testing
p < 0.05
SCI-NP vs. SCI-no NP:
PFC: Mean spectral differences, possible
contributions: NAA, Glu, Glx, Cho, taurine
and GABA.
ACC: Mean spectral differences, possible
contributions: Ins and Asp. Thalamus:
not significant
Pattany et al. (64) MRS Thalamus Post hoc t-tests
p < 0.05
SCI-NP vs. SCI-no NP:
↓ NAA and NAA/Ins.
Pain intensity correlated negatively with
NAA levels.
Pain intensity correlated positively with
Ins levels
Results of studies investigating differences between SCI-NP and SCI-no NP subjects unless stated otherwise. Study order is based on neuroimaging modality as reported in Table 1,
starting with structural, DTI, rsfMRI, then MRS. ACC, anterior cingulate cortex; Asp, aspartate; BG, basal ganglia; CC, corpus callosum; Cho, choline; Cr, creatine; CST, corticospinal
tract; DTI, diffusion tensor imaging; dlPM, dorsolateral premotor cortex; FA, fractional anisotropy; FC, functional connectivity; FDR, false-discovery rate; FWE, family-wise error; GABA,
gamma (γ )-aminobutyric acid; Glu, glutamate; Glx, glutamate and glutamine; GMV, gray matter volume; Ins, Myo-inositol; k, minimum cluster size; L, left; M1, motor cortex; MD, mean
diffusivity; mFG, medial frontal gyrus; mOFC, medial orbital frontal cortex; MRS, magnetic resonance spectroscopy; NAA, N-acetyl aspartate; PET, positron emission tomography; PFC,
prefrontal cortex; PMC, premotor cortex; PPC, posterior parietal cortex; R, right; rsfMRI, resting-state fMRI; S1, somatosensory cortex 1; S2, somatosensory cortex 2; SCI, spinal cord
injury; SLF, superior longitudinal fasciculus; SMA, supplementary motor area; sMRI, structural MRI; SCI NP, SCI subjects with NP; SCI no NP, SCI subjects without NP; SVC, small
volume correction; TFCE, threshold-free cluster enhancement; vlPM, ventrolateral premotor cortex; WMV, white matter volume.
↔ No significant changes; ↑ significant increase; ↓ significant decrease.
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TABLE 4 | Neuroimaging studies investigating SCI subjects with NP compared to healthy controls.
References Modality Region of interest(s) Statistical correction Main findings
Jutzeler et al. (55) sMRI Whole brain;
M1, S1, S2, PMC,
insula, thalamus and
ACC as regions of
interests
p < 0.05 FWE correction SCI-NP vs. controls:
↑ GMV in ACC. ↓ GMV in Thalamus
Mole et al. (56) sMRI Whole brain:
M1, S1, thalamus,
L posterior cingulate, R
insula as regions
of interests
p < 0.001 uncorrected;
p < 0.05 FWE correction
SCI-NP vs. controls:
↔GMV.
↓ WMV of bilateral pyramids, L medial cuneus, deep
to L S2 and R posterior corona radiata
Min et al. (59)§ rsfMRI M1, SMA, S1, S2, BG,
dlPM, vlPM
p < 0.05,
k = 64 FDR correction
SCI-pain vs. controls:
↓ FC:
• R M1—R S1, R S2
• R S1—L S1, R S2, L S2
• L S1—R S2
• R S2—R dlPM
↑ FC:
• R M1—R SMA, L
SMA
• L BG—L S2
Yoon et al. (57) sMRI
DTI
PET
Whole brain sMRI and PET:
p < 0.001 uncorrected,
p < 0.05 SVC with 10mm
spheres;
DTI: p < 0.05 TFCE
SCI-NP vs. controls:
↓ GMV in L mFG, R ACC and bilateral anterior insula
↓ MD: splenium and body of CC, R SLF, CST
regions, thalamocortical tract, superior parietal white
matter, R pre and post central, bilateral superior
frontal and middle frontal area, cerebral peduncle,
anterior corona radiata and internal capsule. ↔ FA
↓ metabolism in L middle frontal gyrus and R mFG
Gustin et al. (58) DTI Whole brain p < 0.005 uncorrected,
k = 20
SCI-NP vs. controls:
↑ MD of dorsolateral PFC, PPC and PMC
↓ MD in ventroposterior thalamus, amygdala and
ventral pons
↔ FA
Widerström- Noga
et al. (60)
MRS Thalamus Independent t tests
p < 0.05
SCI-NP high pain vs. controls:
↓ NAA/Ins and Glx/Ins
SCI-NP low pain vs. controls:
↔ metabolite concentrations
Gustin et al. (61) MRS Thalamus Independent t tests
p < 0.05
SCI-NP vs. controls:
↓ NAA/Cr and GABA/Cr
Widerström-Noga
et al. (62)
MRS ACC Independent t tests
p < 0.05
SCI -NP high pain vs. controls:
↑ Glx/Ins
SCI-NP low pain vs. controls: n/a
Stanwell et al. (63) MRS Thalamus,
PFC, and ACC
Wavelet-based significant
testing
p < 0.05
SCI-NP vs. controls: n/a
Pattany et al. (64) MRS Thalamus Post hoc t tests
p < 0.05
SCI-NP vs. controls:
↔ NAA and NAA/Ins
Results of studies investigating differences between SCI-NP subjects and healthy controls unless stated otherwise. Study order is based on neuroimaging modality as reported in
Table 1, starting with structural, DTI, rsfMRI, then MRS.
ACC, anterior cingulate cortex; BG, basal ganglia; CC, corpus callosum; Cr, creatine; CST, corticospinal tract; DTI, diffusion tensor imaging; dlPM, dorsolateral premotor cortex; FA,
fractional anisotropy; FC, functional connectivity; FDR, false-discovery rate; FWE, family-wise error; GABA, gamma (γ )-aminobutyric acid; Glx, glutamate and glutamine; GMV, gray matter
volume; Ins, myo-inositol; k, minimum cluster size; L, Left; M1, motor cortex; MD, mean diffusivity; mFG, medial frontal gyrus; MRS, magnetic resonance spectroscopy; NAA, N-acetyl
aspartate; PET, positron emission tomography; PFC, prefrontal cortex; PMC, premotor cortex; PPC, posterior parietal cortex; R, right; rsfMRI, resting-state fMRI; S1, somatosensory
cortex 1; S2, somatosensory cortex 2; SCI, spinal cord injury; SLF, superior longitudinal fasciculus; SMA, supplementary motor area; sMRI, structural MRI; SCI NP, SCI subjects with
NP; SCI no NP, SCI subjects without NP; SVC, small volume correction; TFCE, threshold-free cluster enhancement; vlPM, ventrolateral premotor cortex; WMV, white matter volume.
↔ No significant changes; ↑ significant increase; ↓ significant decrease.
Three studies reported a range of volumetric changes (54–56).
Decreased GMVwere observed in the left superior parietal lobule
(53), left hippocampus, and superior and middle frontal gyrus
(54). Increased GMV of bilateral primary somatosensory cortex
(S1), left cuneus (56), and ACC (55) were also observed in SCI
subjects without NP compared to healthy controls. Decreased
WMV were observed in the right temporal and occipital areas
(53) alongside the pyramidal region and posterior corona radiata
(56) in SCI subjects without NP. One study did not observe any
WMV differences (54).
Microstructural brain changes in SCI subjects without NP
was reported in one study (58). Eleven chronic SCI subjects
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TABLE 5 | Neuroimaging studies investigating SCI subjects without NP compared to healthy controls.
References Modality Region of interest(s) Statistical correction Main findings
Chen et al. (53) sMRI Whole brain; S1, M1 and
thalamus as region of interests
p < 0.05 cluster-level
corrected
SCI-no pain vs. controls:
↓ GMV in L superior parietal lobule
↓ WMV in R temporal lobe, R occipital
lobe and R calcarine gyrus
Chen et al. (54) sMRI
rsfMRI
Whole brain sMRI: p < 0.0001
uncorrected,
p < 0.05 cluster-level FWE
correction;
rsfMRI: p < 0.05 k = 30
(Monte Carlo simulation)
SCI-no pain vs. controls:
↓ GMV in L hippocampus, L
parahippocampal gyrus, R superior
and middle frontal gyrus
↔ WMV
↓ ALFF in L OFC
↓ intranetwork FC in L middle occipital
gyrus
Jutzeler et al. (55) sMRI Whole brain; M1, S1, S2, PMC,
insula, thalamus, and ACC as
regions of interests
p < 0.05 FWE SCI-no NP vs. controls:
↓ GMV in ACC and M1
Mole et al. (56) sMRI Whole brain:
M1, S1, thalamus,
L posterior cingulate, R insula as
regions of interests
p < 0.001 uncorrected;
p < 0.05 FWE correction
SCI-no NP vs. controls:
↑ GMV in bilateral S1 and L lateral cuneus
↓ WMV of bilateral pyramids and posterior
corona radiata
Gustin et al. (58) DTI Whole brain p < 0.005 uncorrected,
k = 20
SCI-no NP vs. controls:
↓ FA of PPC-to-midbrain fibers
↓ MD of anterior insula, PPC and
dorsolateral PFC, nucleus accumbens,
ventroposterior thalamus and PMC
Gustin et al. (61) MRS Thalamus Independent t tests
p < 0.05
SCI-no NP vs. controls:
No significance
Widerström-Noga et al.
(62)
MRS ACC Independent t tests
p < 0.05
SCI-no NP vs. controls:
No significance
Stanwell et al. (63) MRS Thalamus, PFC, and ACC Wavelet-based significant
testing
p < 0.05
SCI-no NP vs. controls: n/a
Pattany et al. (64) MRS Thalamus Post hoc t tests
p < 0.05
SCI-no NP vs. controls:
↔ NAA
↑ NAA/Ins
↓ Ins
Results of studies investigating differences between SCI-no NP subjects and healthy controls unless stated otherwise. Study order is based on neuroimaging modality as reported in
Table 1, starting with structural, DTI, rsfMRI, then MRS.
ACC, anterior cingulate cortex; ALFF, amplitude of low-frequency fluctuations; DTI, diffusion tensor imaging; FA, fractional anisotropy; FWE, family-wise error; GMV, gray matter volume;
Ins, myo-inositol; k, minimum cluster size; L, left; M1, motor cortex; MD, mean diffusivity; mFG, medial frontal gyrus; MRS, magnetic resonance spectroscopy; NAA, N-acetyl aspartate;
PFC, prefrontal cortex; PMC, premotor cortex; PPC, posterior parietal cortex; R, right; rsfMRI, resting-state fMRI; S1, somatosensory cortex 1; S2, somatosensory cortex 2; SCI, spinal
cord injury; sMRI, structural MRI; NP, neuropathic pain; SCI NP, SCI subjects with NP; SCI no NP, SCI subjects without NP; WMV, white matter volume.
↔ No significant changes; ↑ significant increase; ↓ significant decrease.
without NP showed decreased FA of fibers connecting the parietal
cortex to the midbrain and decreased MD of the premotor and
PFC, parietal region, anterior insula, nucleus accumbens, and
ventroposterior thalamus (58).
Connectivity changes in acute SCI subjects without pain
were reported in one study (54). This study observed decreased
amplitude of low-frequency fluctuations in the left orbitofrontal
cortex, which correlated negatively with subjects’ motor scores
alongside decreased intranetwork rsFC of the left middle occipital
gyrus in the medial visual network (54) (Table 5).
Metabolite concentrations of SCI subjects without NP were
reported in three studies (61, 62, 64). Two studies observed no
differences in the ACC or thalamus (61, 62) in SCI subjects
without NP compared to controls. In contrast, one study reported
increased NAA/Ins ratio and decreased Ins in the thalamus of
nine chronic paraplegic SCI subjects without NP compared to
controls (64) (Table 5).
DISCUSSION
The primary purpose of this review was to examine the results
of current studies that investigated the correlates of chronic NP
in brain structure, function, and metabolite changes following
SCI. With the adoption of strict exclusion and inclusion criteria
in this review (Figure 1, Table 1), current neuroimaging studies
report a range of changes in SCI subjects with NP dependent
on the comparison to particular cohorts, i.e., to healthy
controls or SCI subjects without NP (Tables 3, 4). Some studies
report changes in metabolite concentrations within sensory
and pain-related regions of SCI subjects with NP compared
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to those without (Table 3). In addition, a couple of studies
report bidirectional volumetric changes, and there remains little
evidence of microstructural changes in SCI subjects with NP
(Table 3). Moreover, in comparison to healthy controls, there
remains limited evidence of volumetric, microstructural, and
connectivity changes but a range of alterations in metabolite
concentrations in SCI subjects with NP (Table 4). Furthermore,
the few studies included here report bidirectional volumetric
changes in SCI subjects without NP, and there is limited evidence
of microstructure and metabolite alterations in these subjects
(Table 4).
NP Following SCI Is Associated With
Changes in Brain Metabolites and
Structure
Current studies that investigated the influence of NP within SCI
show primarily metabolite concentration changes in sensory-
pain-related regions (i.e., thalamus and ACC) and bidirectional
changes in brain volume and microstructure (Table 3, Figure 2).
Within the thalamus of SCI subjects with NP, decreases
in NAA ratios to Ins or Cr could be indicative of a loss of
neuronal density and dysfunction of inhibitory neurons (61, 64).
As decreases in NAA/Cr ratio were positively correlated with
the reduction in GABA/Cr ratios, this supports a disruption of
normal inhibitory function in SCI subjects with NP compared to
those without (61). In addition, Pattany et al., showed negative
and positive correlations of NAA and Ins with greater pain
intensity, respectively, suggesting neuronal and glial changes and
its involvement with pain intensity (64). Moreover, Widerström-
Noga et al., reported a decrease in NAA/Ins ratio and Glx/Ins
ratio in SCI subjects with intenseNP compared to those withmild
NP, suggesting a contribution of lower glutamatergic metabolism,
increased glial proliferation, or hypertrophy in the thalamus of
SCI subjects with more intense NP (60). Similar decreases in
NAA/Ins ratio were reported within the ACC in SCI subjects with
intense NP compared to those with mild NP (62). This possibly
indicates a combination of neuronal dysfunction and gliosis, as
absolute concentrations of NAA were not significantly different
in SCI subjects with intense NP compared to controls or SCI
subjects without NP (62) (Table 3). Furthermore, compared to
SCI subjects without NP, SCI subjects with intense NP showed
decreased Glx and Glx/Ins ratio, suggesting reduced synaptic
activity which may explain the greater amount of emotional
distress in this cohort (62), as the ACC is involved in the
affective component of pain and descending pain modulation
(5, 65–67). To support this view, an earlier study also concluded
that mean spectral differences of MRS data within the ACC
and PFC delineated SCI subjects with and without NP (63).
Structural changes in SCI subjects with NP may be bidirectional,
i.e., decreases in GMV in S1 and increases in GMV in M1
both correlate positively with higher pain intensity (55, 56)
(Table 3). Decreases in GMV of pain-related regions are often
attributed to maladaptive structural plasticity (68–70), whereas
increases in GMV reflect preserved structure (also known as
“persistent representation”), which correlates to pain intensity
(71). In chronic pain conditions, decreases in GMV in sensory-
pain-related areas can stem from a variety of factors, i.e.,
nociceptive input, neurodegeneration, and vascular changes (68,
72, 73). Increases in GMV could be attributed to dendritic
branching, neurogenesis, and axonal sprouting (74), and indeed,
in subjects with SCI, it has been shown that reorganization
of S1 may be attributed to lateral dendritic growth (75). Such
bidirectional changes have been previously shown in functional
studies in SCI subjects with NP, either reporting increased
cortical reorganization (“maladaptive cortical plasticity”) or no
change in cortical reorganization (“persistent representation”)
correlating positively with higher pain intensity (20, 76). These
findings are also reported in functional studies of deafferentated
subjects with phantom limb pain (71, 77), and a computational
study suggests that these two models are driven by the same
underlying mechanism, i.e., abnormal increase in spontaneous
activity of deafferented nociceptive pathways (18, 78). It is
therefore possible that similar processes occur in SCI subjects
with NP reflected in the opposing volumetric changes. One
study observed bidirectional microstructural changes in areas
involved with spatial cognition, sensory, motor, and affective-
motivational functions of SCI subjects with NP (58) (Table 3).
Increases in MD were positively correlated with pain intensity
in the prefrontal cortex and anterior insula (58), indicating
microstructural alterations in regions involved with the cognitive
and emotional aspects of pain (58). Decreased MD was positively
correlated with pain intensity in the thalamus and amygdala
(58), again indicating microstructural changes can be related to
pain phenotype. Overall, this may suggest microglial changes
that mediate the inflammatory process in SCI subjects with
NP as activated microglia are higher in numbers with different
phenotypes (larger cell bodies and thicker and shorter processes)
(79). It is recognized that activated microglia may contribute
to the chronification of NP through hyperexcitability of the
sensory neuroaxis and disruption of GABAergic transmission
after SCI (80–82).
Brain Changes Accompanying Both SCI
and NP
Although the effects of SCI-related NP remain difficult to
disentangle without subgroups of SCI subjects without NP, some
studies report the associated brain changes in SCI and NP by
comparing these subjects directly to healthy controls (Table 4).
A couple of studies investigated volumetric changes between
SCI subjects withNP to controls.Mole et al., observed onlyWMV
decreases in regions of projection pathways with no changes
in GMV (56), whereas Yoon et al., reported GMV decreases
within the medial frontal gyrus, ACC, and anterior insula (57).
These limited results may suggest an impact of SCI and NP upon
affective-motivational, pain modulatory, and cognitive function,
as Yoon et al., also reported decreased glucose metabolism of
the frontal areas within the same cohort (57). Furthermore,
microstructural alterations were reported in a couple of studies
and may indicate bidirectional changes in water diffusion that
accompany SCI and NP (57, 58). Decreased MD was observed
in multiple brain regions including the thalamus, amygdala,
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FIGURE 2 | Schematic overview of neuroimaging studies reporting brain differences in SCI subjects with NP compared to SCI subjects without NP. Red brain areas
indicate region reported to be affected in articles included in the qualitative synthesis. Labeled boxes describe the type of alteration reported in the brain region. ACC,
Anterior Cingulate Cortex; Cr, Creatine; GABA, y-aminobutyric acid; Glx, Glutamate and Glutamine; GMV, Gray Matter Volume; Ins, Myo-inositol; Ml, Prinmy Motor
Cortex; MD, Mean Diffusivity; mOFC, Medial Orbitofrontal Cortex; NAA, N-acetyl aspattate; PFC, Prefrontal Cortex; PMC, Premotor Cortex; PPC, Posterior Parietal
Cortex; Sl, Primary Somatosensory Cortex; S2, Secondary Somatosensory Cortex; WMV, White Matter Volume. ↓ Significant decrease; ↑ Significant increase.
sensorimotor cortices, and brainstem regions of SCI subjects with
NP (57, 58) (Table 4). These decreases could be due to changes in
underlying cell properties (i.e., shape and density) and increased
extracellular matrix (83). In contrast, both increased MD (58)
and decreased MD (57) was observed in the frontal and parietal
cortices (Table 4), which suggests glial/neuronal alterations or
inflammation (i.e., edema) (30, 83, 84) that accompanies regions
involved with emotional or spatial cognition following SCI and
NP. Both studies did not report any changes in FA, suggesting
that axonal integrity may not be compromised in SCI and
NP at the supraspinal level (57, 58). Connectivity changes
within the sensory and motor cortices were observed in one
study of 18 incomplete SCI subjects with a varying degree of
pain (59). In particular, rsFCs between motor regions were
significantly increased while rsFC decreases were seen between
sensory regions (59) (Table 4). These results suggest that the
impact of incomplete SCI may result in cortical rsFC changes
due to damage to primary afferents, loss of sensory feedback,
and recruitment of motor regions to compensate for the motor
deficit (59). Although the authors suggested that pain was not
a contributing factor to rsFC changes as no correlations were
observed with pain intensity (59), the presence of pain itself
cannot be fully overlooked. A few studies observed changes
in metabolite concentrations in sensory-pain-related regions of
chronic SCI subjects with NP, i.e., ACC and thalamus (60–62).
Compared to controls, SCI subjects with NP showed decreased
NAA, Glx, and GABA ratios within the thalamus (60, 61)
(Table 4), suggesting lower glutamatergic metabolism, loss of
neuronal density, and dysfunction of inhibitory neurons that
accompanies SCI and NP (38, 60, 61). Although one study did
not observe changes in thalamus metabolite concentrations (64),
this may be due to the small number of SCI subjects with NP (n
= 7) (Tables 3, 4). Changes in metabolite concentrations within
the ACC were observed in one study; decreased Glx ratio was
observed in SCI subjects with a high NP intensity, suggesting
decreased glutamatergic activity that may contribute to their
affective distress (62). In the same study, SCI subjects with a
lower NP intensity did not show changes in ACC metabolite
concentrations compared to healthy controls, suggesting that NP
intensity may be reflected in this affective-motivational pain-
related region (62).
Trauma-Induced Brain Changes Following
SCI
Based on the articles included here, there is small evidence
of volumetric changes in acute and chronic SCI without the
presence of NP, but limited evidence on microstructural and
metabolite changes in this condition (Table 5).
In acute and incomplete SCI subjects, Chen et al., observed
decreased GMV and WMV of regions involved with spatial
cognition, memory function, and visual processing (53, 54),
which is additionally highlighted by decreases in amplitudes of
low-frequency fluctuations within the orbitofrontal cortex and
rsFC of the medial visual network (54). These observations
could highlight the initial impairment of SCI upon the
subjects’ movement ability and related brain changes in
visuospatial cognitive processing (53, 54). Interestingly, in
chronic SCI subjects, increased GMV in areas processing
vision (cuneus), sensory information (S1) (56), and affective-
motivational/emotional cognition (ACC) was observed (55),
whereas decreases in WMV were observed in pathways
of projection fibers associated with motor function, i.e.,
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corticospinal tract (56). These volumetric alterations may reflect
the damage and cell atrophy to the sensorimotor system,
alongside compensatory mechanisms that could accompany
chronic SCI subjects without NP, i.e., visual compensation due
to lack of sensory feedback (56) and adaptive mechanisms of
sensory-pain-related regions in the absence of NP (55, 56).
Indeed, S1 and ACC are involved with the sensory-discriminative
(85) and affective-motivational/descending control aspects of
pain (65, 66), respectively. Microstructural changes in white
matter were reported in one study by Gustin et al., showing
decreased FA of parietal cortex to midbrain fibers, alongside
decreases in MD in cortices involved with executive, motor,
sensory, and emotional function (58) (Table 5). Within these
regions, decreased FA could reflect impaired axonal integrity
or axonal degeneration, whereas decreased MD could reflect
changes in neuronal cells, i.e., proliferation or sprouting (30,
83, 86) that may accompany chronic sensorimotor complete
SCI without NP (58). Two out of three studies investigating
metabolite concentrations in chronic SCI subjects without NP
show non-significant changes in the ACC or thalamus (61, 62).
However, only one study reported decreases in absolute Ins
within the thalamus, which could indicate alterations of glial cells
following SCI (64) as Ins is considered a glial marker (38).
Demographics of SCI Subgroups
In general, recruitment of SCI subjects remains difficult; however,
controlling the heterogeneity may limit confounds between
studies. As summarized in Table 2, current studies include
primarily an older cohort of subjects (majority being male) with
a chronic SCI. A recent meta-analysis by Burke et al. (1), which
included 1,401 SCI subjects, observed a 53% overall prevalence
of NP. Further analysis concluded that NP was found to be
more prevalent 1 year postinjury, in people aged 50 or older and
tetraplegics (1). However, the prevalence of NP with regard to sex
and completeness was not presented due to insufficient data and
remains unclear (1). Interestingly, in the studies included here,
the presence of NP can be observed in SCI subjects with a range of
completeness, level of injury, and pain intensity (Table 2). Three
studies were able to include a very homogeneous cohort of SCI
subjects, i.e., thoracic level of injury and sensorimotor complete,
only delineating the subjects based on NP (58, 61, 63). Another
included a restricted criterion of injury level (C5 to T5) although
liberal with regard to completeness (56). The remaining studies
included an array of injury level and completeness alongside NP
(55, 57, 60, 62, 64) (Table 2). As the primary aim of these studies
were to observe NP changes in SCI subjects, the sum of the SCI
cohort may not allow further differentiation.
Overall, it is unclear in the studies included in this review how
the heterogeneity of SCI subjects with NP confounds the brain
alterations observed (i.e., structure, function, and metabolite
changes). This limiting factor could be explored in future studies
within a large cohort allowing comparisons for example between
different lesion levels of SCI with NP (thoracic vs. cervical SCI
subjects with NP).
Methodological Considerations
Alongside the demographics of SCI subjects within each study,
it is important to consider the method implemented, i.e.,
modality, quantity of cohort, and statistical thresholds. All
studies that investigated structural changes with VBM at a
whole brain level corrected for multiple comparisons using
regions of interests or spheres (i.e., p < 0.05 family-wise error
or cluster-level correction; Tables 3–5). Statistical thresholds
remain controversial based on factors such as sample size,
i.e., a lower threshold (i.e., uncorrected levels) may be more
suitable due to a small quantity of subjects; however, the number
of false-positive results also increase (87). Utilizing regions of
interests as a small volume correction also increases the chance
of significant results; hence, regions selected should ideally be in
accordance with a priori hypothesis shown in a previous work
(88). Furthermore, as the VBM studies included here reported
volumetric changes by modulating the structural images, the gray
matter density changes that accompany NP following SCI remain
to be reported. Interestingly, the two DTI studies included here
(57, 58) utilized different toolboxes for data analysis, i.e., FMRIB
Software Library (89) and Statistical Parametric Mapping (90),
which may yield differing results due to differing preprocessing
steps. These two studies also differ in subjects recruited as Yoon
et al., did not include a SCI cohort without NP (57) (Table 2);
hence, more DTI studies are needed. Another discrepancy
between each study is the spatial resolutions of the method, i.e.,
MRS can only investigate particular regions of interest compared
to whole brain MRI (i.e., sMRI, DTI, and rsfMRI). To date,
only the ACC and thalamus have been reported with MRS; thus,
other pain-related regions, i.e., insula, remain to be explored in
future studies.
Taken together, methodological differences in future studies
may be observed based on the cohort recruited for the
hypotheses, neuroimaging modality, or parameters alongside the
toolbox and statistical threshold used for data analysis. Therefore,
this field may benefit from open data sources and data sharing
between SCI centers, in particular the detailed demographics
of SCI subjects, the technical parameters of the particular
scanner utilized, and the available dataset (i.e., structural MRI,
rsfMRI data).
Limitations
This review is constrained by some important limitations. First,
for the purpose of this review, we included a strict criterion
(clear information regarding pain) and excluded multiple studies
(Supplementary Table 2). Therefore, the overall effects of SCI
on the brain may be overlooked. Indeed, previous studies
have shown longitudinal structural changes within sensorimotor
regions and white matter pathways (91, 92) and microstructural
and rsFC changes [see reviews and meta-analysis: (44–47)].
Second, we excluded task-based functional results that may
reflect the cortical reorganization due to the presence of
NP following SCI, and indeed, the direction of functional
reorganization and its correlation to pain can be debated after
deafferentation, i.e., in phantom-limb and SCI (20, 21, 71,
76, 77). Third, the papers on supraspinal changes included
here were broadly discussed within the neuroimaging method;
hence, the underlying interpretations require clarification using a
multimodal approach (i.e., neuroimaging, neurophysiology, and
clinical assessment) or available animal models. In addition, this
review did not discuss studies that investigated pain processing
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exclusively in the spinal cord, and certainly, this structure is
involved in descending pain modulation and pain processing
(93–96). Finally, this review did not include a meta-analyses
due to the small number of studies alongside the differing
methodologies used (Tables 1–5). Instead, an overview of the
reported alterations in neuroanatomical landmarks (based on
the imaging method) and its correlation with possible biological
changes in the SCI condition was reported. This review may also
overlook studies that utilized surface-based methods compared
to voxel-based approaches.
CONCLUSION
The aim of this review was to compile the neuroimaging findings
that provide evidence of supraspinal alterations after SCI with
NP under no task conditions. Overall, there is some evidence
suggesting that the magnitude and presence of NP following
SCI results in both adaptive and maladaptive structural plasticity
of sensorimotor regions, alongside altered metabolism of brain
areas involved with descending painmodulation, pain perception
(i.e., ACC and PFC), and sensory integration (i.e., thalamus and
S1). In SCI subjects with NP, there remains two reproducible
findings: decreases in NAA within the thalamus (60, 61, 64) and
decreased GMV of the primary somatosensory cortex (55, 56)
(Figure 2). However, based on the fact that only a few studies
investigated volumetric, microstructural, and glucose metabolic
changes in chronic SCI subjects with NP (55–58), the underlying
mechanisms that accompany such changes in these cohorts
remain to be further elucidated.
Future cross-sectional studies that aim to disentangle NP
within the SCI condition may require stricter constraints
in subject cohorts with broader characterization of SCI, i.e.,
integrity of afferent pathways (complete, incomplete) (51), and
pain (including NP) as this may confound the results. In addition
to standardizing protocols and scanning sequences, an approach
to deal with the problem of cohorts heterogeneity might be the
advancement of statistical methods to understand the multiple
complex interactions of SCI subjects’ characteristics and their
effects on neuroplasticity. Cumbersome, longitudinal studies will
be vital to understand the alterations of supraspinal areas that
accompany NP in SCI subjects. Although there are three studies
which have investigated SCI subjects longitudinally (91, 97, 98),
with one being a training study (97), changes associated with
NP still remain unclear. These studies did not subgroup the SCI
cohort into a NP/non-NP group (possibly due to low numbers)
(91, 98) (Supplementary Table 2). However, one study reported
a positive correlation over 6 months with greater NP intensity
and increased iron levels (as measured by quantitative MRI) in
the right S2, left ACC, and bilateral cerebellum (98), which may
further indicates altered pain processing. In contrast, another
study was unable to observe any structural changes in the brain
(or spinal cord), which were related to NP longitudinally (91).
These results remain to be replicated in future longitudinal
studies, which may additionally benefit from the utilization of
improved pain phenotyping, i.e., pain drawings, questionnaires,
etc. (99) alongside tracking the start of pain development.
Taken together, such considerations may allow classifications of
the clinical, neurophysiological, and neuroimaging subtypes of
NP in SCI subjects, provide additional insight to the complex
mechanism of NP, and discover sensitive biomarkers that profile
pain and optimize treatment.
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